Deutsch English Français

Contact

EP1874723

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1874723

EP1874723 - NEW NITROGENATED TRANS-STILBENE ANALOGS, METHOD FOR THE OBTENTION AND MEDICAL APPLICATIONS THEREOF [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 09.11.2012 Database last updated on 02.11.2024
Most recent event Tooltip	09.11.2012	Application deemed to be withdrawn	published on 12.12.2012 [2012/50]
Applicant(s)	For all designated states Dominion Pharmakine S.L. Edificio 801A, 1a planta Parque Tecnol gico di Bizkaia 48160 Derio (bizkaia) / ES
	For all designated states UNIVERSIDAD DEL PAIS VASCO B[deg] Sarriena s/n 48940 Leioa (Bizkaia) / ES
	[2008/02]
Inventor(s)	01 / COSSÍO, Fernando Pedro Universidad del País Vasco, B Sarriena s/n. 48940 Leioa (bizkaia) / ES
	02 / ALDABA ARÉVALO, Eneko Universidad del País Vasco, B Sarriena s/n. 48940 Leioa (bizkaia) / ES
	03 / VARA SALAZAR, Yosu Ion Universidad del País Vasco, B Sarriena s/n. 48940 Leioa (bizkaia) / ES
	04 / ZUBIA OLASCOAGA, Aizpea Universidad del País Vasco, B Sarriena s/n. 48940 Leioa (bizkaia) / ES
	05 / VIVANCO AMATO, Silvia Universidad del País Vasco, B Sarriena s/n. 48940 Leioa (bizkaia) / ES
	06 / MENDOZA ARTECHE, Miren L., Dominion Pharmakine S.L Ed. 801a, 1 Pl., Parque Tecnol gico De Bizkaia 48160 Derio (bizkaia) / ES
	07 / SALADO POGONZA, Clarisa, Dominion Pharmakine S.L. Ed. 801a, 1 Pl., Parque Tecnol gico De Bizkaia 48160 Derio (bizkaia) / ES
	08 / GALLOT ESCOBAL, Natalia, Dominion Pharmakine S.L. Ed. 801a, 1 Pl., Parque Tecnol gico De Bizkaia 48160 Derio (bizkaia) / ES
	09 / VIDAL VANACLOCHA, Fernando Dominion Pharmakine S.L Ed. 801a, 1 Pl., Parque Tecnol gico De Bizkaia 48160 Derio (bizkaia) / ES
	[2008/02]
Representative(s)	Pons Ariño, Angel Pons Patentes y Marcas Internacional, S.L. Glorieta Rubén Dario 4 28010 Madrid / ES
	[N/P]
Former [2008/39]	Pons Arino, Angel Pons Patentes y Marcas Internacional, S.L. Glorieta Ruben Dario 4 28010 Madrid / ES
Former [2008/02]	Pons Arino, Angel Glorieta Rubén Dario N[deg] 4 28010 Madrid / ES
Application number, filing date	06743291.4	12.04.2006
	[2008/02]
	WO2006EP61565
Priority number, date	US20050671669P	15.04.2005 Original published format: US 671669 P
	[2008/02]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2006108864
	Date:	19.10.2006
	Language:	EN
	[2006/42]
	Type:	A2 Application without search report
	No.:	EP1874723
	Date:	09.01.2008
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 19.10.2006 takes the place of the publication of the European patent application.
	[2008/02]
Search report(s)	International search report - published on:	EP	29.03.2007
Classification	IPC:	C07C251/24, C07D207/40, C07D207/42, C07D209/12, A61K31/13, A61K31/40, A61K31/404, A61P35/00	[2008/02]
	CPC:	C07D207/416 (EP,US); A61P35/00 (EP); C07C251/24 (EP,US); C07D207/42 (EP,US); C07D209/12 (EP,US)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/02]
Extension states	AL	Not yet paid
	BA	Not yet paid
	HR	Not yet paid
	MK	Not yet paid
	YU	Not yet paid
Title	German:	NEUE NITROGENIERTE TRANSSTILBEN-ANALOGE, VERFAHREN ZU DEREN GEWINNUNG UND MEDIZINISCHE ANWENDUNGEN DAMIT	[2008/02]
	English:	NEW NITROGENATED TRANS-STILBENE ANALOGS, METHOD FOR THE OBTENTION AND MEDICAL APPLICATIONS THEREOF	[2008/02]
	French:	NOUVEAUX ANALOGUES DE TRANS-STILBENE AZOTES, PROCEDE D'OBTENTION DE CES ANALOGUES ET APPLICATIONS MEDICALES CORRESPONDANTES	[2008/02]
Entry into regional phase	15.11.2007	National basic fee paid
	15.11.2007	Designation fee(s) paid
	15.11.2007	Examination fee paid
Examination procedure	15.11.2007	Examination requested [2008/02]
	12.01.2010	Despatch of a communication from the examining division (Time limit: M06)
	15.07.2010	Reply to a communication from the examining division
	07.02.2012	Despatch of a communication from the examining division (Time limit: M04)
	19.06.2012	Application deemed to be withdrawn, date of legal effect [2012/50]
	20.07.2012	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2012/50]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 12.01.2010
Fees paid	Renewal fee
	02.05.2008	Renewal fee patent year 03
	17.04.2009	Renewal fee patent year 04
	03.05.2010	Renewal fee patent year 05
	02.05.2011	Renewal fee patent year 06
	26.03.2012	Renewal fee patent year 07
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	SU1085979 [ ] (KZ FIZ TEKH I [SU]);
		[X]WO9323364 (RHONE POULENC RORER SA [FR], et al) [X] 1,2,18-30 * page 5: formula IV * * page 19, line 10 *;
		[X]WO9323357 (RES CORP TECHNOLOGIES INC [US]) [X] 1,2,6,19-30 * page 89: compound 108c, 108d *;
		[X] - KIM S ET AL, "Design, Synthesis, and Discovery of Novel trans-Stilbene Analogues as Potent and Selective Cytochrome P450 1B1 Inhibitors", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, (2002), vol. 45, no. 1, ISSN 0022-2623, pages 160 - 164, XP002313146 [X] 1,2,6,18-30 * compound 11 * DOI: http://dx.doi.org/10.1021/jm010298j
		[X] - CUSHMAN M ET AL, "SYNTHESIS AND EVALUATION OF A SERIES OF BENZYLANILINE HYDROCHLORIDES AS POTENTIAL CYTOTOXIC AND ANTIMITOTIC AGENTS ACTINGBY INHIBITION OF TUBULIN POLYMERIZATION", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, (19930917), vol. 36, no. 19, ISSN 0022-2623, pages 2817 - 2821, XP000571678 [X] 1,2,6 * compound 8c, 8d * DOI: http://dx.doi.org/10.1021/jm00071a012
		[X] - HEO, YOEN HOI ET AL, "Induction of quinone reductase activity by stilbene analogs in mouse Hepa 1c1c7 cells", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 136:303565, URL: STN, XP002407364 [X] 1,2,6,18-30 * abstract *
		[X] - SUN, LICHUN ET AL, "Examination of the 1,4-disubstituted azetidinone ring system as a template for combretastatin A-4 conformationally restricted analogue design", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 141:54094, URL: STN, XP002407365 [X] 1,2,6 * abstract *
		[X] - GALYAMETDINOV, YU. G. ET AL, "Copper complexes with 4,4-dialkoxy-2-hydroxybenzalaniline as liquid crystal paramagnetic spin probes and 4,4-dialkoxy-2- hydroxybenzalanilines", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 101:102799, URL: STN, XP002407366 [X] 1,2 * abstract *
		[XP] - YOO, KYUNG MI ET AL, "Potent inhibitory effects of resveratrol derivatives on progression of prostate cancer cells", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 145:284321, URL: STN, XP002407367 [XP] 1,2,6,18-30 * abstract *
		[Y] - KIM Y-A ET AL, "ANTIPROLIFERATIVE EFFECT OF RESVERATROL IN HUMAN PROSTATE CARCINOMA CELLS", JOURNAL OF MEDICINAL FOOD, MARY ANN LIEBERT, LARCHMONT, NY,, US, (200312), vol. 6, no. 4, ISSN 1096-620X, pages 273 - 280, XP009067993 [Y] 1-30 * the whole document * DOI: http://dx.doi.org/10.1089/109662003772519813
		[Y] - AGGARWAL B B ET AL, "ROLE OF RESVERATROL IN PREVENTION AND THERAPY OF CANCER: PRECLINICAL AND CLINICAL STUDIES", ANTICANCER RESEARCH, HELENIC ANTICANCER INSTITUTE, ATHENS,, GR, (2004), vol. 24, no. 5A, ISSN 0250-7005, pages 2783 - 2840, XP009065753 [Y] 1-30 * the whole document *
	Examination	- HEO, YOEN HOI ET AL, "Induction of quinone reductase activity by stilbene analogs in mouse Hepa 1c1c7 cells", ARCH PHARM RES, (2001), vol. 24, no. 6, pages 597 - 600

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p